European Biotech Acquisition - Warrants (06/03/2026) Other Current Liabilities

As of the most recent data (December 2022), EBACW shows a other current liabilities of $440K. That compares with $450K in the prior-year period — down 2.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EBACW's other current liabilities is now $440K (was $450K) — a 2.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether European Biotech Acquisition - Warrants (06/03/2026) is outperforming or lagging.

Tracking EBACW's other current liabilities over time shows whether European Biotech Acquisition - Warrants (06/03/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $440K That compares with $450K in the prior-year period — down 2.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has European Biotech Acquisition - Warrants (06/03/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $440K) with ownership activity and broader fundamentals.